Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gabriel Steg

Showing results (381-390 of 1,113) with videos related to

Pageof 112
Sort By:
Circulation. Cardiovascular Interventions|May 12, 2016
Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized TrialsGeorge D Dangas, Mikkel M Schoos, Philippe Gabriel Steg, et al.
The American Journal of Cardiology|June 30, 2007
Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events)Debabrata Mukherjee, Kim A Eagle, Eva Kline-Rogers, et al.
Journal of the American College of Cardiology|January 14, 2022
Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-ITNickpreet Singh, Deepak L Bhatt, Michael Miller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary diseaseStéphane Manzo-Silberman, Pascale Nicaise-Roland, Catherine Neukirch, et al.
International Journal of Cardiology|August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registryFabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
European Heart Journal|January 17, 2009
Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary EventsPh Gabriel Steg, Keith A A Fox, Kim A Eagle, et al.
Circulation. Genomic and Precision Medicine|May 11, 2022
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES TrialWilliam A Murphy, Nan Lin, Amy Damask, et al.
European Heart Journal|December 17, 2009
Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary eventsKeith A A Fox, Kathryn Carruthers, Ph Gabriel Steg, et al.
American Heart Journal|May 26, 2009
Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary EventsKaren S Pieper, Joel M Gore, Gordon FitzGerald, et al.
Journal of the American Heart Association|December 30, 2022
Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary InterventionGuillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, et al.
Pageof 112

Showing results (381-390 of 1,113) with videos related to

Sort By:
Pageof 112
Circulation. Cardiovascular Interventions|May 12, 2016
Early Stent Thrombosis and Mortality After Primary Percutaneous Coronary Intervention in ST-Segment-Elevation Myocardial Infarction: A Patient-Level Analysis of 2 Randomized TrialsGeorge D Dangas, Mikkel M Schoos, Philippe Gabriel Steg, et al.
The American Journal of Cardiology|June 30, 2007
Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events)Debabrata Mukherjee, Kim A Eagle, Eva Kline-Rogers, et al.
Journal of the American College of Cardiology|January 14, 2022
Consistency of Benefit of Icosapent Ethyl by Background Statin Type in REDUCE-ITNickpreet Singh, Deepak L Bhatt, Michael Miller, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
Effect of rapid desensitization on platelet inhibition and basophil activation in patients with aspirin hypersensitivity and coronary diseaseStéphane Manzo-Silberman, Pascale Nicaise-Roland, Catherine Neukirch, et al.
International Journal of Cardiology|August 27, 2021
Generalizability of the REDUCE-IT trial and cardiovascular outcomes associated with hypertriglyceridemia among patients potentially eligible for icosapent ethyl therapy: An analysis of the REduction of Atherothrombosis for Continued Health (REACH) registryFabien Picard, Deepak L Bhatt, Grégory Ducrocq, et al.
European Heart Journal|January 17, 2009
Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary EventsPh Gabriel Steg, Keith A A Fox, Kim A Eagle, et al.
Circulation. Genomic and Precision Medicine|May 11, 2022
Pharmacogenomic Study of Statin-Associated Muscle Symptoms in the ODYSSEY OUTCOMES TrialWilliam A Murphy, Nan Lin, Amy Damask, et al.
European Heart Journal|December 17, 2009
Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary eventsKeith A A Fox, Kathryn Carruthers, Ph Gabriel Steg, et al.
American Heart Journal|May 26, 2009
Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary EventsKaren S Pieper, Joel M Gore, Gordon FitzGerald, et al.
Journal of the American Heart Association|December 30, 2022
Femoral Vascular Closure Devices and Bleeding, Hemostasis, and Ambulation Following Percutaneous Coronary InterventionGuillaume Marquis-Gravel, Laurie-Anne Boivin-Proulx, Zhen Huang, et al.
Pageof 112